in  10%  of  severe  preeclampsia.    It  increases 
plasma  concentration  and  trombocyte 
activation.   
 
Data  of  Indonesian  Health  Ministry  in  2010-2013 
showed  that  hypertension  was  the  second  cause  of 
maternal  mortality  in  Indonesia  after  bleeding 
(Kemenkes  RI,  2014).    High  rate  of  preeclampsia 
must  be  followed  by  effective  preventive  and 
treatment that still need a lot of researches.     
Some researches for treatment and prevention of 
preeclampsia can not be done in human.  So we need 
animal  model  that  will  be  similar  to  preeclampsia.  
The researches about animal model of preeclampsia 
were  very  variated  and  need  to  be  confirmed  with 
cellular and clininal examanations.   
One  of  researches  about  preeclampsia  animal 
model was endothelialial dysfunction model.  It was 
made  by  Sulistyowati  et.  al.  (2010)  as  induction  of 
preeclampsia.    That  endothelial  dysfunction  model 
was  done  by  injecting  anti  QA2  (anti  Human  QA 
Lymphocyte  Antigen  2  Region).    It  blocked  QA2 
expression in placenta.  
Placental  QA2  expression  was  homolog  to 
human  leucocyte  antigen-G  expression (HLA-G)  in 
human.  Low HLA-G in trophoblast was a predictor 
to  endothelial  dysfunction  in  preeclampsia.    That 
reasearch showed that endotel dysfunction model in 
Mus musculus cauesd HSP70, VCAM-1 and matrix 
metalloproteinase (MMP9) profiles that were similar 
with women with preeclampsia (Sulistyowati et. al., 
2010).  That research did not examine clinical 
examanations  that  appeared  from  endothelial 
dysfunction. 
The goal of this research was making endothelial 
dysfunction  in  pregnant  Mus  musculus  that  was 
injected  by  anti  QA2  and  confirming  urine 
examanation  (protein,  creatinine,  and  UACR  urine) 
as  one  of  preeclampsia  clinical  manifestations 
because  of  endothelial  dysfunction  and  low  renal 
function.
   
 
2.  MATERIAL DAN METHOD 
 
This  research  was  true  experimental  with  post  test 
only with control group design.  This research used 
female  Mus musculus that  was  mated  by  male Mus 
musculus.    Female  Mus  musculus  with  positive 
vaginal plug were used in the research.  The vaginal 
plug  was  the  sign  those  female  and  male  Mus 
musculus were mated and the pregnant was called 0 
day.   
Mus musculus that were used must be 3 months, 
healthy,  bodyweight  15-25  grams,  well  moving,  no 
wound  found  in  the  body,  and  clear  eye.    This 
research used 3 pregant Mus musculus/groups.  The 
duration  of  research  was  2  weeks,  consisted  of 
acclimatization,  mating  female  and  male  Mus 
musculus, intervention, and termination.   
All  of  female  Mus musculus  were  injected  by 
pregnant  mare  serum  gonadothropine  (PMSG)  and 
human  chorionic  gonadotropine  (HCG)  to  equate 
oestrus  cycle.    Female  Mus musculus  was  injected 
by 5 IU PMSG intra peritoneal, after 48 hours they 
were  injected  again  by  HCG  5  IU  intra  peritoneal.  
After  that,  female  Mus  musculus  were  mated  by 
male Mus musculus 1:1.   
Tomorow morning after mating, female and male 
Mus musculus  were  seperated.    Female  Mus 
musculus were examined if they had positive vaginal 
plug or not.  Pregnant Mus musculus were who had 
positive  vaginal  plug,  and  randomize  into  7  groups 
(3 pregnant Mus musculus/group). 
The  location  was  in  Laboratory  of  Embriology, 
Faculty  of  Veterinery,  Airlangga  University.    This 
research  consisted  of  7  groups:  K0  (control,  no 
injection  of  anti  QA2),  K1  (anti  QA2  10  ng),  K2 
(anti  QA2  20  ng),  K3  (anti  QA2  30  ng),  K4  (anti 
QA2  40  ng),  K5  (anti  QA2  50  ng),  and  K6  (anti 
QA2 60 ng).     
K1 was injected by anti QA2 10 ng (0,1 ml) intra 
peritoneal in the first day of pregnant, and examined 
in the second  day of pregnant.   K2 was injected by 
anti  QA2 10  ng  (0,1  ml)  intraperitoneal in  the  first 
and  second  day  of  pregnant,  and  examined  in  the 
third day of pregnant.  K3 was
 injected by anti QA2 
10  ng  (0,1  ml)  intraperitoneal  in  the  first,  second, 
and  third  day  of  pregnant,  and  examined  in  the 
fourth  day  of  pregnant.    K4  was  injected  by  anti 
QA2  10  ng  (0,1  ml)  intra  peritoneal  in  the  first, 
second,  third,  and  fourth  day  of  pregnant,  and 
examined in the fifth of pregnant.  K5  was injected 
by  anti  QA2  10  ng  (0,1  ml)  intra  peritoneal  in  the 
first, second, third, fourth, and fifth day of pregnant, 
and examined in the sixth day of pregnant.  K6 was 
injected by anti QA2 10 ng (0,1 ml) intra peritoneal 
in the first, second, third, fourth, fifth, and sixth day 
of  pregnant,  and  examined  in  the  seventh  day  of 
pregnant.   
Urine  of  Mus musculus  was  tooken  in  the 
morning  and  was  examined  for  protein,  creatinin, 
and  UACR  to  analyze  endothelial  dysfunction  and 
low renal function.